One of the things to note on the impact, too, is we are finding that athletes are now failing the impact test on purpose so that their baseline is now lower to start out with. So that if in fact the concussion occurs, they dont have to get back to what truly is their normal baseline. But one that has been fabricated because of choices theyve made during the testtaking. So this is about changing the nature of this injury as well. And really getting people to care about their brains so that they dont make choices like that. And in this case, you mean, that that enables them to get back out on the field. Correct. It takes it takes their baseline and lowers it. So that their results dont have to come back to what is their normal baseline. I see. They wouldnt take that impact until the day after. Correct. Youre doing sort of a quick and dirty on the side lines, to decide whether they can go back in immediately or not. Then you are holding thep out and doing that, you know, check towards bas
Good afternoon and welcome. Im councilman joe pitts. Welcome to the 16th Congressional District of pennsylvania. For your information, this meeting will be streamed live. Cspan is here. So you might want to keep that in mind. But id like to welcome everyone here, especially our distinguished panelists. And i have a short introductory comment to set the stage. Through the 21st century initiative, congress is taking a comprehensive look at the full arc of accelerating cures. From the discovery of clues and basic science, to streamlining the drug and Device Development process, to unleashing the power of medicine and social media the at treatment delivery phase. And this cycle of discovery and development and delivery is what saves lives. And we want this cycle to work effectively and efficiently so theres no gap between the 21st century science and the washington regulatory process. This work will be a collaborative effort which is why we are first listening to experts and involved parti
USA News Group News Commentary – As the 2024 American Society of Clinical Oncology (ASCO) annual meeting approaches, excitement builds over the latest in cancer treatment advancements, particularly in Antibody-Drug Conjugates (ADCs). From May 31 .
USA News Group: Emerging Trends in Oncology: ASCO 2024 Highlights Next-Gen Antibody-Drug Conjugates and More finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Emerging Trends in Oncology: ASCO 2024 Highlights Next-Gen Antibody-Drug Conjugates and More prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.